Asset
Cholic acid
Mirum Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01115582 | phase3 | completed | 2010-04-01 | 2010-08-01 | Mirum Pharmaceuticals, Inc. | Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid Synthesis |
| NCT01438411 | phase3 | completed | 2010-01-01 | 2016-07-01 | Mirum Pharmaceuticals, Inc. | Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid Synthesis |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 205750 | NDA | MIRUM PHARMACEUTICALS INC |
Marketed products (2)
- CHOLBAM
- CHOLBAM